Videos

4 experts are featured in this series

Long-term patient-reported outcomes and dedicated objective sleep assessments offer complementary views of treatment response. The panel examines what OASIS-3 and NIRVANA add to the evolving evidence on VMS and sleep. Fifty-two-week data support durable improvement in VMS and sleep, while concordance across polysomnography, home monitoring, and sleep diaries strengthens confidence that benefits extend beyond patient perception.